Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 793
Filtrar
1.
Breast Cancer Res Treat ; 195(3): 223-236, 2022 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-35918499

RESUMEN

PURPOSE: Arylamine N-acetyltransferase 1 (NAT1) deficiency has been associated with drug resistance and poor outcomes in breast cancer patients. The current study aimed to investigate drug resistance in vitro using normal breast cancer cell lines and NAT1-deficient cell lines to understand the changes induced by the lack of NAT1 that resulted in poor drug response. METHODS: The response to seven chemotherapeutic agents was quantified following NAT1 deletion using CRISPR-Cas 9 in MDA-MB-231 and T-47D cells. Apoptosis was monitored by annexin V staining and caspase 3/7 activity. Cytochrome C release and caspase 8 and 9 activities were measured by Western blots. Caspase 8 was inhibited using Z-IETD-FMK and necroptosis was inhibited using necrostatin and necrosulfonamide. RESULTS: Compared to parental cells, NAT1 depleted cells were resistant to drug treatment. This could be reversed following NAT1 rescue of the NAT1 deleted cells. Release of cytochrome C in response to treatment was decreased in the NAT1 depleted cells, suggesting suppression of the intrinsic apoptotic pathway. In addition, NAT1 knockout resulted in a decrease in caspase 8 activation. Treatment with necrosulfonamide showed that NAT1 deficient cells switched from intrinsic apoptosis to necroptosis when treated with the anti-cancer drug cisplatin. CONCLUSIONS: NAT1 deficiency can switch cell death from apoptosis to necroptosis resulting in decreased response to cytotoxic drugs. The absence of NAT1 in patient tumours may be a useful biomarker for selecting alternative treatments in a subset of breast cancer patients.


Asunto(s)
Antineoplásicos , Arilamina N-Acetiltransferasa , Neoplasias de la Mama , Antineoplásicos/farmacología , Antineoplásicos/uso terapéutico , Apoptosis , Arilamina N-Acetiltransferasa/deficiencia , Arilamina N-Acetiltransferasa/genética , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/genética , Neoplasias de la Mama/metabolismo , Caspasa 8/genética , Caspasa 8/metabolismo , Caspasa 8/uso terapéutico , Muerte Celular , Citocromos c/metabolismo , Citocromos c/uso terapéutico , Femenino , Humanos , Isoenzimas/deficiencia , Isoenzimas/genética , Necroptosis
2.
Protein Expr Purif ; 189: 105928, 2022 01.
Artículo en Inglés | MEDLINE | ID: mdl-34217803

RESUMEN

The protease present in a host may reduce the yield and biological activity of heterologous proteins. In this study, we used protease overexpression and deletion strategies to examine the effect of the Clp protease system in Corynebacterium glutamicum on the recombinant protein and to produce a highly efficient heterologous protein expression host. In this study, we identified seven genes in the Clp protease family in Corynebacterium glutamicum ATCC 13032 through bioinformatics analysis, and studied their effects on the enhanced green fluorescent protein (EGFP) reporter protein. The fluorescence intensity of the knockout strain was significantly higher, and the effect of the clpS deletion strain was the most obvious. To verify the universal effect of the lack of clpS, the excellent industrial strain C. glutamicum 1.15647 was transformed to form recombinant 15647-ΔclpS. Based on the results, 15647-ΔclpS had a more significant effect on improving protein expression. Furthermore, recombinant human teriparatide (rhPTH) and variable domain of heavy chain of heavy-chain antibody (VHH) were selected to verify the universal applicability of the knockout strain for expressing heterologous proteins. Accordingly, we found that protease deficiency could increase the production of heterologous proteins. Finally, through a large-scale fermentation, the 15647-ΔclpS strain was used to produce VHH. Its yield was approximately 530 mg/L, which was 65% higher than that of WT-15647. In this study, a host that could effectively increase heterologous protein expression was successfully obtained.


Asunto(s)
Corynebacterium glutamicum/genética , Endopeptidasa Clp/genética , Regulación Bacteriana de la Expresión Génica , Cadenas Pesadas de Inmunoglobulina/biosíntesis , Teriparatido/metabolismo , Biología Computacional/métodos , Corynebacterium glutamicum/enzimología , Endopeptidasa Clp/deficiencia , Fermentación , Técnicas de Inactivación de Genes , Genes Reporteros , Proteínas Fluorescentes Verdes/genética , Proteínas Fluorescentes Verdes/metabolismo , Humanos , Cadenas Pesadas de Inmunoglobulina/genética , Cadenas Pesadas de Inmunoglobulina/aislamiento & purificación , Isoenzimas/deficiencia , Isoenzimas/genética , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/genética , Proteínas Recombinantes/aislamiento & purificación , Teriparatido/aislamiento & purificación , Transgenes
3.
Biochem Biophys Res Commun ; 546: 59-64, 2021 03 26.
Artículo en Inglés | MEDLINE | ID: mdl-33571905

RESUMEN

Adenylate kinase2 (AK2) catalyzes trans-compartmental nucleotide exchange, but the functional implications of this mitochondrial intermembrane isoform is only partially understood. Here, transgenic AK2-/- null homozygosity was lethal early in embryo, indicating a mandatory role for intact AK2 in utero development. In the adult, conditional organ-specific ablation of AK2 precipitated abrupt heart failure with Krebs cycle and glycolytic metabolite buildup, suggesting a vital contribution to energy demanding cardiac performance. Depressed pump function recovered to pre-deletion levels overtime, suggestive of an adaptive response. Compensatory upregulation of phosphotransferase AK1, AK3, AK4 isozymes, creatine kinase isoforms, and hexokinase, along with remodeling of cell cycle/growth genes and mitochondrial ultrastructure supported organ rescue. Taken together, the requirement of AK2 in early embryonic stages, and the immediate collapse of heart performance in the AK2-deficient postnatal state underscore a primordial function of the AK2 isoform. Unsalvageable in embryo, loss of AK2 in the adult heart was recoverable, underscoring an AK2-integrated bioenergetics system with innate plasticity to maintain homeostasis on demand.


Asunto(s)
Adenilato Quinasa/metabolismo , Desarrollo Embrionario , Homeostasis , Miocardio/enzimología , Miocardio/metabolismo , Adaptación Fisiológica , Adenilato Quinasa/deficiencia , Adenilato Quinasa/genética , Animales , Ciclo del Ácido Cítrico , Pérdida del Embrión , Desarrollo Embrionario/genética , Metabolismo Energético , Femenino , Eliminación de Gen , Genes Esenciales/genética , Glucólisis , Insuficiencia Cardíaca/genética , Insuficiencia Cardíaca/fisiopatología , Homeostasis/genética , Isoenzimas/deficiencia , Isoenzimas/genética , Isoenzimas/metabolismo , Masculino , Ratones , Ratones Transgénicos
4.
Biochim Biophys Acta Proteins Proteom ; 1869(1): 140540, 2021 01.
Artículo en Inglés | MEDLINE | ID: mdl-32971287

RESUMEN

A two-dimensional (2D) HPLC system focusing on the determination of phenylalanine (Phe) enantiomers in mammalian physiological fluids has been developed. ᴅ-Phe is indicated to have potential values as a disease biomarker and therapeutic molecule in several neuronal and metabolic disorders, thus the regulation of ᴅ-Phe in mammals is a matter of interest. However, the precise determination of amino acid enantiomers is difficult in complex biological samples, and the development of an analytical method with practically acceptable sensitivity, selectivity and throughput is expected. In the present study, a 2D-HPLC system equipped with a reversed-phase column in the 1st dimension and an enantioselective column in the 2nd dimension has been designed, following the fluorescence derivatization of the target amino acid enantiomers with 4-fluoro-7-nitro-2,1,3-benzoxadiazole (NBD-F). The analytical method was validated using both plasma and urine samples, and successfully applied to human, rat and mouse fluids. Trace levels of ᴅ-Phe were determined in the plasma, and the %ᴅ values were around 0.1% for all species. In the urine, relatively large amounts of ᴅ-Phe were observed, and the %ᴅ values for humans, rats and mice were 3.99, 1.76 and 5.25%, respectively. The relationships between the enzymatic activity of ᴅ-amino acid oxidase (DAO) and the amounts of intrinsic ᴅ-Phe have also been clarified, and high ᴅ-Phe amounts were observed (around 0.3% in the plasma and around 50% in the urine) in the DAO deficient rats and mice.


Asunto(s)
Cromatografía Líquida de Alta Presión/métodos , D-Aminoácido Oxidasa/deficiencia , Fenilalanina , Animales , Animales Modificados Genéticamente , Cromatografía Líquida de Alta Presión/normas , D-Aminoácido Oxidasa/sangre , Humanos , Isoenzimas/sangre , Isoenzimas/deficiencia , Masculino , Ratones , Ratones Endogámicos C57BL , Fenilalanina/sangre , Fenilalanina/orina , Ratas , Ratas Endogámicas F344 , Sensibilidad y Especificidad , Estereoisomerismo , Adulto Joven
5.
Neurosci Lett ; 735: 135206, 2020 09 14.
Artículo en Inglés | MEDLINE | ID: mdl-32593773

RESUMEN

Inositol-1,4,5-trisphosphate 3-kinase-A (ITPKA) is the neuronal isoform of ITPKs and exhibits both actin bundling and InsP3kinase activity. In addition to neurons, ITPKA is ectopically expressed in tumor cells, where its oncogenic activity increases tumor cell malignancy. In order to analyze the physiological relevance of ITPKA, here we performed a broad phenotypic screening of itpka deficient mice. Our data show that among the neurobehavioral tests analyzed, itpka deficient mice reacted faster to a hotplate, prepulse inhibition was impaired and the accelerating rotarod test showed decreased latency of itpka deficient mice to fall. These data indicate that ITPKA is involved in the regulation of nociceptive pathways, sensorimotor gating and motor learning. Analysis of extracerebral functions in control and itpka deficient mice revealed significantly reduced glucose, lactate, and triglyceride plasma concentrations in itpka deficient mice. Based on this finding, expression of ITPKA was analyzed in extracerebral tissues and the highest level was found in the small intestine. However, functional studies on CaCo-2 control and ITPKA depleted cells showed that glucose, as well as triglyceride uptake, were not significantly different between the cell lines. Altogether, these data show that ITPKA exhibits distinct functions in the central nervous system and reveal an involvement of ITPKA in energy metabolism.


Asunto(s)
Neuronas/enzimología , Fosfotransferasas (Aceptor de Grupo Alcohol)/deficiencia , Inhibición Prepulso/fisiología , Animales , Células CACO-2 , Femenino , Humanos , Isoenzimas/deficiencia , Isoenzimas/genética , Masculino , Ratones , Ratones Noqueados , Fosfotransferasas (Aceptor de Grupo Alcohol)/genética
6.
Cell Rep ; 31(9): 107715, 2020 06 02.
Artículo en Inglés | MEDLINE | ID: mdl-32492424

RESUMEN

Previous studies have suggested that the loss of the translation initiation factor eIF4G1 homolog NAT1 induces excessive self-renewability of naive pluripotent stem cells (PSCs); yet the role of NAT1 in the self-renewal and differentiation of primed PSCs is still unclear. Here, we generate a conditional knockout of NAT1 in primed PSCs and use the cells for the functional analyses of NAT1. Our results show that NAT1 is required for the self-renewal and neural differentiation of primed PSCs. In contrast, NAT1 deficiency in naive pluripotency attenuates the differentiation to all cell types. We also find that NAT1 is involved in efficient protein expression of an RNA uridyltransferase, TUT7. TUT7 is involved in the neural differentiation of primed PSCs via the regulation of human endogenous retrovirus accumulation. These data demonstrate the essential roles of NAT1 and TUT7 in the precise transition of stem cell fate.


Asunto(s)
Diferenciación Celular , Retrovirus Endógenos/metabolismo , Neuronas/citología , Células Madre Pluripotentes/citología , ARN Viral/metabolismo , Animales , Arilamina N-Acetiltransferasa/deficiencia , Arilamina N-Acetiltransferasa/genética , Arilamina N-Acetiltransferasa/metabolismo , Línea Celular , Linaje de la Célula , Autorrenovación de las Células , Retrovirus Endógenos/genética , Edición Génica , Humanos , Isoenzimas/deficiencia , Isoenzimas/genética , Isoenzimas/metabolismo , Ratones , Neuronas/metabolismo , Iniciación de la Cadena Peptídica Traduccional , Células Madre Pluripotentes/metabolismo , Interferencia de ARN , ARN Nucleotidiltransferasas/genética , ARN Nucleotidiltransferasas/metabolismo , ARN Interferente Pequeño/metabolismo , ARN Viral/antagonistas & inhibidores , Factores de Transcripción/genética , Factores de Transcripción/metabolismo
7.
Nucleic Acids Res ; 48(1): 332-348, 2020 01 10.
Artículo en Inglés | MEDLINE | ID: mdl-31777930

RESUMEN

Single-strand specific endoribonuclease YbeY has been shown to play an important role in the processing of the 3' end of the 16S rRNA in Escherichia coli. Lack of YbeY results in the accumulation of the 17S rRNA precursor. In contrast to a previous report, we show that Sinorhizobium meliloti YbeY exhibits endoribonuclease activity on single-stranded RNA substrate but not on the double-stranded substrate. This study also identifies the previously unknown metal ion involved in YbeY function to be Zn2+ and shows that the activity of YbeY is enhanced when the occupancy of zinc is increased. We have identified a pre-16S rRNA precursor that accumulates in the S. meliloti ΔybeY strain. We also show that ΔybeY mutant of Brucella abortus, a mammalian pathogen, also accumulates a similar pre-16S rRNA. The pre-16S species is longer in alpha-proteobacteria than in gamma-proteobacteria. We demonstrate that the YbeY from E. coli and S. meliloti can reciprocally complement the rRNA processing defect in a ΔybeY mutant of the other organism. These results establish YbeY as a zinc-dependent single-strand specific endoribonuclease that functions in 16S rRNA processing in both alpha- and gamma-proteobacteria.


Asunto(s)
Proteínas de Escherichia coli/genética , Escherichia coli/genética , Metaloproteínas/genética , ARN Ribosómico 16S/genética , Sinorhizobium meliloti/genética , Zinc/metabolismo , Emparejamiento Base , Cationes Bivalentes , Pruebas de Enzimas , Escherichia coli/metabolismo , Expresión Génica , Prueba de Complementación Genética , Isoenzimas/deficiencia , Isoenzimas/genética , Metaloproteínas/deficiencia , Mutación , Conformación de Ácido Nucleico , Precursores del ARN/genética , Precursores del ARN/metabolismo , ARN Bicatenario/genética , ARN Bicatenario/metabolismo , ARN Ribosómico 16S/metabolismo , Sinorhizobium meliloti/metabolismo
8.
BMC Res Notes ; 12(1): 726, 2019 Nov 06.
Artículo en Inglés | MEDLINE | ID: mdl-31694723

RESUMEN

OBJECTIVE: To describe the genetic variants in the ARSA gene in Sri Lankan patients with metachromatic leukodystrophy (MLD). As the variant profile of MLD in the Sri Lankan population is currently unknown. RESULTS: Twenty patients from eighteen Sri Lankan families were screened for ARSA gene mutations. We found 13 different genetic variants of these three were novel. The three novel variants were p.Asp281Asn, p.Asp283Asn, p.Ala344Asp. Seven patients out of 20 were also positive for the pseudodeficiency (PD) allele c.1049A>G (p.Asn350Ser). This is the first report to describe the molecular genetic variants of Sri Lankan patients with MLD.


Asunto(s)
Cerebrósido Sulfatasa/genética , Predisposición Genética a la Enfermedad/genética , Leucodistrofia Metacromática/genética , Mutación Missense , Adolescente , Adulto , Alelos , Cerebrósido Sulfatasa/deficiencia , Niño , Preescolar , Análisis Mutacional de ADN/métodos , Humanos , Lactante , Recién Nacido , Isoenzimas/deficiencia , Isoenzimas/genética , Persona de Mediana Edad , Sri Lanka , Adulto Joven
9.
Mol Pharmacol ; 96(5): 573-579, 2019 11.
Artículo en Inglés | MEDLINE | ID: mdl-31444237

RESUMEN

Arylamine N-acetyltransferase 1 (NAT1) is a drug-metabolizing enzyme that influences cancer cell proliferation and survival. However, the mechanism for these effects is unknown. Because of previous observations that NAT1 inhibition decreases invasiveness, we investigated the expression of the metalloproteinase matrix metalloproteinase 9 (MMP9) in human breast cancer samples and in cancer cells. We found a negative correlation between the expression of NAT1 and MMP9 in 1904 breast cancer samples. Moreover, when NAT1 was deleted in highly invasive breast cancer cells, MMP9 mRNA and protein significantly increased, both of which were reversed by reintroducing NAT1 into the knockout cells. After NAT1 deletion, there was an increased association of acetylated histone H3 with the SET and MYND-domain containing 3 (SMYD3) element in the MMP9 promoter, consistent with an increase in MMP9 transcription. NAT1 deletion also up-regulated hypoxia-inducible factor 1-α (HIF1-α). Treatment of the NAT1 knockout cells with small interfering RNA directed toward HIF1-α mRNA inhibited the increased expression of MMP9. Taken together, these results show a direct inverse relationship between NAT1 and MMP9 and suggest that HIF1-α may be essential for the regulation of MMP9 expression by NAT1. SIGNIFICANCE STATEMENT: The expression of the enzyme NAT1 was found to be negatively correlated with MMP9 expression in tumor tissue from breast cancer patients. In cells, NAT1 regulated MMP9 expression at a transcriptional level via HIF1-α. This finding is important as it may explain some of the pathological features associated with changes in NAT1 expression in cancer.


Asunto(s)
Arilamina N-Acetiltransferasa/deficiencia , Neoplasias de la Mama/metabolismo , Regulación Enzimológica de la Expresión Génica , Regulación Neoplásica de la Expresión Génica , Subunidad alfa del Factor 1 Inducible por Hipoxia/fisiología , Isoenzimas/deficiencia , Metaloproteinasa 9 de la Matriz/biosíntesis , Arilamina N-Acetiltransferasa/genética , Neoplasias de la Mama/genética , Línea Celular Tumoral , Femenino , Técnicas de Inactivación de Genes , Células HT29 , Células HeLa , Humanos , Isoenzimas/genética , Metaloproteinasa 9 de la Matriz/deficiencia
10.
Cancer Cell ; 36(2): 156-167.e7, 2019 08 12.
Artículo en Inglés | MEDLINE | ID: mdl-31378680

RESUMEN

We report that mouse LSL-KrasG12D;Trp53fl/fl (KP)-mediated lung adenocarcinoma (LADC) tumorigenesis can proceed through both PKCι-dependent and PKCι-independent pathways. The predominant pathway involves PKCι-dependent transformation of bronchoalveolar stem cells (BASCs). However, KP mice harboring conditional knock out Prkci alleles (KPI mice) develop LADC tumors through PKCι-independent transformation of Axin2+ alveolar type 2 (AT2) stem cells. Transformed growth of KPI, but not KP, tumors is blocked by Wnt pathway inhibition in vitro and in vivo. Furthermore, a KPI-derived genomic signature predicts sensitivity of human LADC cells to Wnt inhibition, and identifies a distinct subset of primary LADC tumors exhibiting a KPI-like genotype. Thus, LADC can develop through both PKCι-dependent and PKCι-independent pathways, resulting in tumors exhibiting distinct oncogenic signaling and pharmacologic vulnerabilities.


Asunto(s)
Adenocarcinoma del Pulmón/enzimología , Transformación Celular Neoplásica/metabolismo , Genes ras , Isoenzimas/metabolismo , Neoplasias Pulmonares/enzimología , Proteína Quinasa C/metabolismo , Proteína p53 Supresora de Tumor/metabolismo , Vía de Señalización Wnt , Adenocarcinoma del Pulmón/tratamiento farmacológico , Adenocarcinoma del Pulmón/genética , Adenocarcinoma del Pulmón/patología , Células Epiteliales Alveolares/metabolismo , Células Epiteliales Alveolares/patología , Animales , Antineoplásicos/farmacología , Línea Celular Tumoral , Proliferación Celular , Transformación Celular Neoplásica/genética , Transformación Celular Neoplásica/patología , Femenino , Regulación Enzimológica de la Expresión Génica , Regulación Neoplásica de la Expresión Génica , Humanos , Isoenzimas/deficiencia , Isoenzimas/genética , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Pulmonares/genética , Neoplasias Pulmonares/patología , Masculino , Ratones Endogámicos C57BL , Ratones Noqueados , Células Madre Neoplásicas/metabolismo , Células Madre Neoplásicas/patología , Proteína Quinasa C/deficiencia , Proteína Quinasa C/genética , Inhibidores de Proteínas Quinasas/farmacología , Carga Tumoral , Células Tumorales Cultivadas , Proteína p53 Supresora de Tumor/antagonistas & inhibidores , Proteína p53 Supresora de Tumor/deficiencia , Proteína p53 Supresora de Tumor/genética , beta Catenina/genética , beta Catenina/metabolismo
11.
FASEB J ; 33(10): 10668-10679, 2019 10.
Artículo en Inglés | MEDLINE | ID: mdl-31268747

RESUMEN

PLC-ß exerts biologic influences through GPCR. GPCRs are involved in regulating glucose-stimulated insulin secretion (GSIS). Previous studies have suggested that PLC-ßs might play an important role in pancreatic ß cells. However, because of a lack of the specific inhibitors of PLC-ß isozymes and appropriate genetic models, the in vivo function of specific PLC-ß isozymes in pancreatic ß cells and their physiologic relevance in the regulation of insulin secretion have not been studied so far. The present study showed that PLC-ß1 was crucial for ß-cell function by generation of each PLC-ß conditional knockout mouse. Mice lacking PLC-ß1 in ß cells exhibited a marked defect in GSIS, leading to glucose intolerance. In ex vivo studies, the secreted insulin level and Ca2+ response in Plcb1f/f; pancreas/duodenum homeobox protein 1 (Pdx1)-Cre recombinase-estrogen receptor T2 (CreERt2) islets was lower than those in the Plcb1f/f islets under the high-glucose condition. PLC-ß1 led to potentiate insulin secretion via stimulation of particular Gq-protein-coupled receptors. Plcb1f/f; Pdx1-CreERt2 mice fed a high-fat diet developed more severe glucose intolerance because of a defect in insulin secretion. The present study identified PLC-ß1 as an important molecule that regulates ß cell insulin secretion and can be considered a candidate for therapeutic intervention in diabetes mellitus.-Hwang, H.-J., Yang, Y. R., Kim, H. Y., Choi, Y., Park, K.-S., Lee, H., Ma, J. S., Yamamoto, M., Kim, J., Chae, Y. C., Choi, J. H., Cocco, L., Berggren, P.-O., Jang, H.-J., Suh, P.-G. Phospholipase Cß1 potentiates glucose-stimulated insulin secretion.


Asunto(s)
Glucosa/metabolismo , Secreción de Insulina/fisiología , Fosfolipasa C beta/metabolismo , Animales , Línea Celular , Dieta Alta en Grasa/efectos adversos , Intolerancia a la Glucosa/genética , Intolerancia a la Glucosa/metabolismo , Intolerancia a la Glucosa/patología , Proteínas de Homeodominio/genética , Proteínas de Homeodominio/metabolismo , Técnicas In Vitro , Secreción de Insulina/genética , Células Secretoras de Insulina/metabolismo , Células Secretoras de Insulina/patología , Islotes Pancreáticos/metabolismo , Islotes Pancreáticos/patología , Isoenzimas/deficiencia , Isoenzimas/genética , Isoenzimas/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Fosfolipasa C beta/deficiencia , Fosfolipasa C beta/genética , Receptores Acoplados a Proteínas G/metabolismo , Transactivadores/genética , Transactivadores/metabolismo
12.
Biochem Biophys Res Commun ; 514(2): 428-435, 2019 06 25.
Artículo en Inglés | MEDLINE | ID: mdl-31053300

RESUMEN

Excessive oxidative stress induces significant injury and cytotoxicity to neuronal cells. The current study tested expression and the potential function of the circular RNA PRKCI (circPRKCI) in oxidative stress-injured neuronal cells. In cultured SH-SY5Y neuronal cells, hydrogen peroxide (H2O2) downregulated circPRKCI expression, causing accumulation of miR-545 and miR-589, but reduction of their target, the transcription factor E2F7. Importantly, ectopic overexpression of circPRKCI in SH-SY5Y cells significantly attenuated H2O2-induced cytotoxicity. Conversely, siRNA-mediated knockdown of circPRKCI induced SH-SY5Y cell death and apoptosis. Further studies demonstrated that H2O2-induced cytotoxicity in SH-SY5Y cells was inhibited by miR-545/589 inhibitors, but mimicked by miR-545/589 mimics. Importantly, CRISPR/Cas9-mediated knockout (KO) of E2F7 induced potent SH-SY5Y cell death and apoptosis. Furthermore, transfection of circPRKCI siRNA or miR-545/589 mimics were ineffective in E2F7 KO cells. In the primary human neurons, H2O2 stimulation similarly induced circPRKCI downregulation, miR-545/589 accumulation and E2F7 reduction. Moreover, H2O2-induced death and apoptosis in the primary neurons were significantly inhibited by circPRKCI overexpression or miR-545/589 inhibitors. Taken together, our results show that dysregulation of circPRKCI-miR-545/589-E2F7 axis mediated H2O2-induced neuronal cell injury. Targeting this novel cascade could be a fine strategy to protect neurons from oxidative stress.


Asunto(s)
Factor de Transcripción E2F7/genética , Peróxido de Hidrógeno/toxicidad , Isoenzimas/genética , MicroARNs/genética , Neuronas/efectos de los fármacos , Neuronas/patología , Proteína Quinasa C/genética , Apoptosis/efectos de los fármacos , Apoptosis/genética , Línea Celular , Células Cultivadas , Regulación hacia Abajo/efectos de los fármacos , Factor de Transcripción E2F7/deficiencia , Técnicas de Inactivación de Genes , Humanos , Isoenzimas/deficiencia , MicroARNs/metabolismo , Neuronas/metabolismo , Estrés Oxidativo/efectos de los fármacos , Proteína Quinasa C/deficiencia , ARN Interferente Pequeño/genética , Regulación hacia Arriba
14.
J Neurosci ; 39(29): 5773-5793, 2019 07 17.
Artículo en Inglés | MEDLINE | ID: mdl-31101759

RESUMEN

Chronic pain is a serious debilitating disease for which effective treatment is still lacking. Acid-sensing ion channel 1a (ASIC1a) has been implicated in nociceptive processing at both peripheral and spinal neurons. However, whether ASIC1a also contributes to pain perception at the supraspinal level remains elusive. Here, we report that ASIC1a in ACC is required for thermal and mechanical hypersensitivity associated with chronic pain. ACC-specific genetic deletion or pharmacological blockade of ASIC1a reduced the probability of cortical LTP induction and attenuated inflammatory thermal hyperalgesia and mechanical allodynia in male mice. Using cell type-specific manipulations, we demonstrate that ASIC1a in excitatory neurons of ACC is a major player in cortical LTP and pain behavior. Mechanistically, we show that ASIC1a tuned pain-related cortical plasticity through protein kinase C λ-mediated increase of membrane trafficking of AMPAR subunit GluA1 in ACC. Importantly, postapplication of ASIC1a inhibitors in ACC reversed previously established nociceptive hypersensitivity in both chronic inflammatory pain and neuropathic pain models. These results suggest that ASIC1a critically contributes to a higher level of pain processing through synaptic potentiation in ACC, which may serve as a promising analgesic target for treatment of chronic pain.SIGNIFICANCE STATEMENT Chronic pain is a debilitating disease that still lacks effective therapy. Ion channels are good candidates for developing new analgesics. Here, we provide several lines of evidence to support an important role of cortically located ASIC1a channel in pain hypersensitivity through promoting long-term synaptic potentiation in the ACC. Our results indicate a promising translational potential of targeting ASIC1a to treat chronic pain.


Asunto(s)
Canales Iónicos Sensibles al Ácido/biosíntesis , Giro del Cíngulo/metabolismo , Isoenzimas/deficiencia , Neuralgia/metabolismo , Plasticidad Neuronal/fisiología , Dimensión del Dolor/métodos , Proteína Quinasa C/deficiencia , 6-Ciano 7-nitroquinoxalina 2,3-diona/administración & dosificación , Canales Iónicos Sensibles al Ácido/genética , Animales , Células Cultivadas , Giro del Cíngulo/efectos de los fármacos , Isoenzimas/genética , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Ratones Transgénicos , Microinyecciones/métodos , Neuralgia/genética , Neuralgia/prevención & control , Plasticidad Neuronal/efectos de los fármacos , Técnicas de Cultivo de Órganos , Dimensión del Dolor/efectos de los fármacos , Proteína Quinasa C/genética
15.
Cancer Cell ; 35(3): 385-400.e9, 2019 03 18.
Artículo en Inglés | MEDLINE | ID: mdl-30827887

RESUMEN

Increasingly effective therapies targeting the androgen receptor have paradoxically promoted the incidence of neuroendocrine prostate cancer (NEPC), the most lethal subtype of castration-resistant prostate cancer (PCa), for which there is no effective therapy. Here we report that protein kinase C (PKC)λ/ι is downregulated in de novo and during therapy-induced NEPC, which results in the upregulation of serine biosynthesis through an mTORC1/ATF4-driven pathway. This metabolic reprogramming supports cell proliferation and increases intracellular S-adenosyl methionine (SAM) levels to feed epigenetic changes that favor the development of NEPC characteristics. Altogether, we have uncovered a metabolic vulnerability triggered by PKCλ/ι deficiency in NEPC, which offers potentially actionable targets to prevent therapy resistance in PCa.


Asunto(s)
Carcinoma Neuroendocrino/patología , Regulación hacia Abajo , Isoenzimas/deficiencia , Neoplasias de la Próstata/patología , Proteína Quinasa C/deficiencia , Serina/metabolismo , Factor de Transcripción Activador 4/metabolismo , Vías Biosintéticas , Carcinoma Neuroendocrino/genética , Carcinoma Neuroendocrino/metabolismo , Línea Celular Tumoral , Metilación de ADN , Epigénesis Genética , Regulación Neoplásica de la Expresión Génica , Humanos , Masculino , Diana Mecanicista del Complejo 1 de la Rapamicina/metabolismo , Neoplasias de la Próstata/genética , Neoplasias de la Próstata/metabolismo , S-Adenosilmetionina/metabolismo
16.
Int J Biochem Cell Biol ; 110: 84-90, 2019 05.
Artículo en Inglés | MEDLINE | ID: mdl-30836144

RESUMEN

Human arylamine N-acetyltransferase 1 (NAT1) has been widely reported to affect cancer cell growth and survival and recent studies suggest it may alter cell metabolism. In this study, the effects of NAT1 deletion on mitochondrial function was examined in 2 human cell lines, breast carcinoma MDA-MB-231 and colon carcinoma HT-29 cells. Using a Seahorse XFe96 Flux Analyzer, NAT1 deletion was shown to decrease oxidative phosphorylation with a significant loss in respiratory reserve capacity in both cell lines. There also was a decrease in glycolysis without a change in glucose uptake. The changes in mitochondrial function was due to a decrease in pyruvate dehydrogenase activity, which could be reversed with the pyruvate dehydrogenase kinase inhibitor dichloroacetate. In the MDA-MB-231 and HT-29 cells, pyruvate dehydrogenase activity was attenuated either by an increase in phosphorylation or a decrease in total protein expression. These results may help explain some of the cellular events that have been reported recently in cell and animal models of NAT1 deficiency.


Asunto(s)
Arilamina N-Acetiltransferasa/deficiencia , Arilamina N-Acetiltransferasa/genética , Eliminación de Gen , Isoenzimas/deficiencia , Isoenzimas/genética , Mitocondrias/metabolismo , Complejo Piruvato Deshidrogenasa/metabolismo , Transporte Biológico/genética , Regulación Neoplásica de la Expresión Génica , Glucosa/metabolismo , Células HT29 , Humanos , Complejo Piruvato Deshidrogenasa/antagonistas & inhibidores
17.
Eur J Pediatr Surg ; 29(3): 290-297, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29723880

RESUMEN

INTRODUCTION: Prematurity, formula feeding, and early weaning strongly influence enterocyte differentiation. Intestinal alkaline phosphatase (IAP), an endogenous protein expressed in the intestines, is one enzyme that is affected by these factors. IAP supplementation decreases the severity of necrotizing enterocolitis (NEC) injury. We, therefore, hypothesized that prematurity predisposes this population to NEC due to IAP deficiency and investigated IAP expression and function in a neonatal rat model. MATERIALS AND METHODS: Pre- and full-term newborn Sprague-Dawley rat pups were sacrificed on consecutive days of life both after vaginal or cesarean birth and following either breast or formula feeding. RESULTS: Compared with controls, cesarean delivery and formula feeding are associated with lower levels of IAP. The formula-fed pups continued to have low baseline IAP activity. Neither prematurity nor formula feeding led to differences of intestinal injury. CONCLUSION: Prematurity and formula feeding are associated with inhibition of IAP expression and activity. Both may increase the risk of NEC and early enteral supplementation of IAP to newborns at risk of NEC may be of therapeutic benefit.


Asunto(s)
Fosfatasa Alcalina/deficiencia , Enterocolitis Necrotizante/etiología , Enfermedades del Prematuro/etiología , Isoenzimas/deficiencia , Fosfatasa Alcalina/metabolismo , Animales , Animales Recién Nacidos , Biomarcadores/metabolismo , Cesárea/efectos adversos , Enterocolitis Necrotizante/metabolismo , Humanos , Fórmulas Infantiles/efectos adversos , Recién Nacido , Enfermedades del Prematuro/metabolismo , Isoenzimas/metabolismo , Ratas , Ratas Sprague-Dawley , Factores de Riesgo
18.
Nucleus ; 9(1): 431-441, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30059280

RESUMEN

Aberrant levels of histone modifications lead to chromatin malfunctioning and consequently to various developmental defects and human diseases. Therefore, the proteins bearing the ability to modify histones have been extensively studied and the molecular mechanisms of their action are now fairly well understood. However, little attention has been paid to naturally occurring alternative isoforms of chromatin modifying proteins and to their biological roles. In this review, we focus on mammalian KDM2A and KDM2B, the only two lysine demethylases whose genes have been described to produce also an alternative isoform lacking the N-terminal demethylase domain. These short KDM2A/B-SF isoforms arise through alternative promoter usage and seem to play important roles in development and disease. We hypothesise about the biological significance of these alternative isoforms, which might represent a more common evolutionarily conserved regulatory mechanism.


Asunto(s)
Histona Demetilasas con Dominio de Jumonji/metabolismo , Neoplasias/enzimología , Animales , Humanos , Isoenzimas/deficiencia , Isoenzimas/genética , Isoenzimas/metabolismo , Histona Demetilasas con Dominio de Jumonji/deficiencia , Histona Demetilasas con Dominio de Jumonji/genética , Neoplasias/metabolismo
19.
Elife ; 72018 06 19.
Artículo en Inglés | MEDLINE | ID: mdl-29916805

RESUMEN

Hematopoietic stem cells require MLL1, which is one of six Set1/Trithorax-type histone 3 lysine 4 (H3K4) methyltransferases in mammals and clinically the most important leukemia gene. Here, we add to emerging evidence that all six H3K4 methyltransferases play essential roles in the hematopoietic system by showing that conditional mutagenesis of Setd1b in adult mice provoked aberrant homeostasis of hematopoietic stem and progenitor cells (HSPCs). Using both ubiquitous and hematopoietic-specific deletion strategies, the loss of Setd1b resulted in peripheral thrombo- and lymphocytopenia, multilineage dysplasia, myeloid-biased extramedullary hematopoiesis in the spleen, and lethality. By transplantation experiments and expression profiling, we determined that Setd1b is autonomously required in the hematopoietic lineages where it regulates key lineage specification components, including Cebpa, Gata1, and Klf1. Altogether, these data imply that the Set1/Trithorax-type epigenetic machinery sustains different aspects of hematopoiesis and constitutes a second framework additional to the transcription factor hierarchy of hematopoietic homeostasis.


Asunto(s)
Hematopoyesis/genética , Células Madre Hematopoyéticas/metabolismo , N-Metiltransferasa de Histona-Lisina/genética , Homeostasis/genética , Linfopenia/genética , Proteína de la Leucemia Mieloide-Linfoide/genética , Trombocitopenia/genética , Animales , Trasplante de Médula Ósea , Proteínas Potenciadoras de Unión a CCAAT/genética , Proteínas Potenciadoras de Unión a CCAAT/metabolismo , Linaje de la Célula/genética , Factor de Transcripción GATA1/genética , Factor de Transcripción GATA1/metabolismo , Perfilación de la Expresión Génica , Regulación de la Expresión Génica , Genes Letales , Células Madre Hematopoyéticas/citología , N-Metiltransferasa de Histona-Lisina/deficiencia , Isoenzimas/deficiencia , Isoenzimas/genética , Factores de Transcripción de Tipo Kruppel/genética , Factores de Transcripción de Tipo Kruppel/metabolismo , Linfopenia/metabolismo , Linfopenia/patología , Ratones , Ratones Noqueados , Proteína de la Leucemia Mieloide-Linfoide/deficiencia , Bazo/metabolismo , Bazo/patología , Trombocitopenia/metabolismo , Trombocitopenia/patología , Irradiación Corporal Total
20.
Matrix Biol ; 70: 140-157, 2018 09.
Artículo en Inglés | MEDLINE | ID: mdl-29649548

RESUMEN

Since its first description, ADAMTS14 has been considered as an aminoprocollagen peptidase based on its high similarity with ADAMTS3 and ADAMTS2. As its importance for procollagen processing was never experimentally demonstrated in vivo, we generated Adamts14-deficient mice. They are healthy, fertile and display normal aminoprocollagen processing. They were further crossed with Adamts2-deficient mice to evaluate potential functional redundancies between these two highly related enzymes. Initial characterizations made on young Adamts2-Adamts14-deficient animals showed the same phenotype as that of Adamts2-deficient mice, with no further reduction of procollagen processing and no significant aggravation of the structural alterations of collagen fibrils. However, when evaluated at older age, Adamts2-Adamts14-deficient mice surprisingly displayed epidermal lesions, appearing in 2 month-old males and later in some females, and then worsening rapidly. Immunohistological evaluations of skin sections around the lesions revealed thickening of the epidermis, hypercellularity in the dermis and extensive infiltration by immune cells. Additional investigations, performed on young mice before the formation of the initial lesions, revealed that the primary cause of the phenotype was not related to alterations of the epidermal barrier but was rather the result of an abnormal activation and differentiation of T lymphocytes towards a Th1 profile. However, the primary molecular defect probably does not reside in the immune system itself since irradiated Adamts2-Adamts14-deficient mice grafted with WT immune cells still developed lesions. While originally created to better characterize the common and specific functions of ADAMTS2 and ADAMTS14 in extracellular matrix and connective tissues homeostasis, the Adamts2-Adamts14-deficient mice revealed an unexpected but significant role of ADAMTS in the regulation of immune system, possibly through a cross-talk involving mesenchymal cells and the TGFß pathways.


Asunto(s)
Proteínas ADAMTS/inmunología , Dermatitis Atópica/inmunología , Dermis/inmunología , Epidermis/inmunología , Procolágeno/inmunología , Linfocitos T/inmunología , Proteínas ADAMTS/deficiencia , Proteínas ADAMTS/genética , Animales , Diferenciación Celular , Movimiento Celular , Dermatitis Atópica/genética , Dermatitis Atópica/patología , Dermis/patología , Epidermis/patología , Matriz Extracelular/inmunología , Matriz Extracelular/patología , Femenino , Regulación de la Expresión Génica , Inmunidad Innata , Isoenzimas/deficiencia , Isoenzimas/genética , Isoenzimas/inmunología , Masculino , Ratones , Ratones Noqueados , Procolágeno/genética , Transducción de Señal , Linfocitos T/patología , Factor de Crecimiento Transformador beta/genética , Factor de Crecimiento Transformador beta/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA